🔎 Trials Near Me

Home › Type 1 Diabetes › New York › New York City

Type 1 Diabetes clinical trials in New York City, NY

15 studies for Type 1 Diabetes are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

App-Based Certified Diabetes Education Therapy (AB-CDE)

Recruiting
  • Mount Sinai School of Medicine, New York
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07282639

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

RecruitingPhase 3
  • Endocrine Associates of West Village- Site Number : 8400064, New York
  • Columbia University Irving Medical Center- Site Number : 8400009, New York
Ages 1 to 25 · All sexes · Updated Sep 14, 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

RecruitingPhase 1/2
  • Hassenfield Children's Hospital, New York
  • NYU Langone Diabetes & Endocrine Associates, New York
Ages 12 to 35 · All sexes · Updated Sep 11, 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

RecruitingPhase 2
  • Columbia University, New York
Ages 4 to 34 · All sexes · Updated Sep 9, 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

RecruitingPhase 2
  • Columbia University, New York
Ages 8 to 45 · All sexes · Updated Sep 8, 2026 · NCT07142252

HLA Demographics Study in Adults With Type 1 Diabetes

RecruitingObservational study
  • Icahn School of Medicine at Mount Sinai, New York
Ages 18 to 55 · All sexes · Updated Aug 28, 2026 · NCT06860516

Long-Term Outcomes of Teplizumab in Routine Clinical Care

RecruitingObservational study
  • Investigational Site Number: 8400001, New York
All ages · All sexes · Updated Aug 25, 2026 · NCT07360080

APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life

Recruiting
  • Weill Cornell Medicine, New York
Ages 18 to 75 · All sexes · Updated Aug 19, 2026 · NCT07773779

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

RecruitingPhase 1
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
Ages 18 to 55 · All sexes · Updated Aug 10, 2026 · NCT06919354

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

RecruitingObservational study
  • Mount Sinai, New York
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT07676565

Kidney Precision Medicine Project

RecruitingObservational study
  • Mount Sinai, New York
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT04334707

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

RecruitingPhase 4
  • New York VA Hospital, New York
  • NYC Health + Hospitals/Bellevue, New York
  • NYU Langone Health, New York
  • and 1 more
Ages 18 to 89 · All sexes · Updated Dec 29, 2025 · NCT05641753

TrialNet Pathway to Prevention of T1D

RecruitingObservational studyHealthy volunteers welcome
  • Columbia University, New York
Ages 2 to 45 · All sexes · Updated Jul 1, 2025 · NCT00097292

NYSCF Scientific Discovery Biobank

RecruitingObservational study
  • New York Stem Cell Foundation Research Institute, New York
30 Days · All sexes · Updated Mar 3, 2025 · NCT06203106

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

RecruitingObservational studyHealthy volunteers welcome
  • Mt Sinai, New York
0 Days – 99 Years · All sexes · Updated Nov 21, 2023 · NCT06141434

About Type 1 Diabetes

If the pancreas doesn't make needed insulin, causing blood sugar levels to be too high you have type 1 or juvenile diabetes. Learn the signs.

More about Type 1 Diabetes on MedlinePlus

Type 1 Diabetes trials in other cities

Other studies in New York City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.